ReleVote

Medical Innovation Acceleration Act of 2025

Bill Number
H.R. 88
Origin Chamber
House
Congress
119th Congress, Session 1
Policy Area
Health
Status
Introduced
Latest Action
2025-01-03: Referred to the House Committee on Energy and Commerce.
Last Updated
2026-01-14T16:41:01Z

Official Summary

Medical Innovation Acceleration Act of 2025

This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.

The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

Sponsor

Rep. Biggs, Andy [R-AZ-5]

Recent Actions

Bill Versions